Cargando…
Preliminary evaluation of urinary soluble Met as a Biomarker for urothelial carcinoma of the bladder
BACKGROUND: Among genitourinary malignancies, bladder cancer (BCa) ranks second in both prevalence and cause of death. Biomarkers of BCa for diagnosis, prognosis and disease surveillance could potentially help prevent progression, improve survival rates and reduce health care costs. Among several on...
Autores principales: | McNeil, Brian K, Sorbellini, Maximiliano, Grubb, Robert L, Apolo, Andrea, Cecchi, Fabiola, Athauda, Gagani, Cohen, Benjamin, Giubellino, Alessio, Simpson, Haley, Agarwal, Piyush K, Coleman, Jonathan, Getzenberg, Robert H, Netto, George J, Shih, Joanna, Linehan, W Marston, Pinto, Peter A, Bottaro, Donald P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283116/ https://www.ncbi.nlm.nih.gov/pubmed/25335552 http://dx.doi.org/10.1186/1479-5876-12-199 |
Ejemplares similares
-
Characterization of HGF/Met Signaling in Cell Lines Derived From Urothelial Carcinoma of the Bladder
por: Lee, Young H., et al.
Publicado: (2014) -
Autocrine signaling by receptor tyrosine kinases in urothelial carcinoma of the bladder
por: Lee, Young H., et al.
Publicado: (2021) -
Tumor and Plasma Met Levels in Non-Metastatic Prostate Cancer
por: Kaye, Deborah R., et al.
Publicado: (2016) -
Contraceptive Pharmacology and Risk Communication: A Case-Based Flipped Classroom Exercise
por: Ottolenghi, Joseph, et al.
Publicado: (2019) -
Osteoporosis: A Small-Group Case-Based Learning Activity
por: Nguyen, Bianca, et al.
Publicado: (2021)